X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TEVA PHARMA (Israel) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   TEVA PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
TEVA PHARMA
Dec-13
CADILA HEALTHCARE/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs5582,899-   
Low Rs3622,519-   
Sales per share (Unadj.) Rs116.31,663.9-  
Earnings per share (Unadj.) Rs17.9103.9-  
Cash flow per share (Unadj.) Rs23.1238.4-  
Dividends per share (Unadj.) Rs3.5090.99-  
Dividend yield (eoy) %0.83.4 22.7%  
Book value per share (Unadj.) Rs85.41,848.3-  
Shares outstanding (eoy) m1,023.74848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.01.6 242.8%   
Avg P/E ratio x25.726.1 98.7%  
P/CF ratio (eoy) x19.911.4 174.9%  
Price / Book Value ratio x5.41.5 367.2%  
Dividend payout %19.687.5 22.4%   
Avg Mkt Cap Rs m470,6642,297,181 20.5%   
No. of employees `00011.844.9 26.3%   
Total wages/salary Rs m18,5450-   
Avg. sales/employee Rs Th10,072.731,394.2 32.1%   
Avg. wages/employee Rs Th1,569.10-   
Avg. net profit/employee Rs Th1,547.71,961.2 78.9%   
INCOME DATA
Net Sales Rs m119,0491,411,010 8.4%  
Other income Rs m1,1320-   
Total revenues Rs m120,1811,411,010 8.5%   
Gross profit Rs m28,475386,406 7.4%  
Depreciation Rs m5,388114,053 4.7%   
Interest Rs m91127,715 3.3%   
Profit before tax Rs m23,308244,638 9.5%   
Minority Interest Rs m6281,111 56.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-160,592 0.0%   
Tax Rs m5,644-2,987 -189.0%   
Profit after tax Rs m18,29288,145 20.8%  
Gross profit margin %23.927.4 87.3%  
Effective tax rate %24.2-1.2 -1,983.4%   
Net profit margin %15.46.2 246.0%  
BALANCE SHEET DATA
Current assets Rs m82,005952,991 8.6%   
Current liabilities Rs m60,720831,089 7.3%   
Net working cap to sales %17.98.6 207.0%  
Current ratio x1.41.1 117.8%  
Inventory Days Days7391 80.5%  
Debtors Days Days9896 102.5%  
Net fixed assets Rs m83,703460,867 18.2%   
Share capital Rs m1,0243,473 29.5%   
"Free" reserves Rs m86,4210-   
Net worth Rs m87,4451,567,365 5.6%   
Long term debt Rs m25,551721,481 3.5%   
Total assets Rs m180,6533,224,611 5.6%  
Interest coverage x26.69.8 270.5%   
Debt to equity ratio x0.30.5 63.5%  
Sales to assets ratio x0.70.4 150.6%   
Return on assets %10.63.6 295.8%  
Return on equity %20.95.6 372.0%  
Return on capital %22.04.9 445.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,4410-   
CASH FLOW
From Operations Rs m9,193224,842 4.1%  
From Investments Rs m-9,737-79,671 12.2%  
From Financial Activity Rs m515-269,713 -0.2%  
Net Cashflow Rs m-29-124,542 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 69.46 Rs / USD

Compare CADILA HEALTHCARE With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare CADILA HEALTHCARE With: PIRAMAL ENTERPRISES  GLENMARK PHARMA  CIPLA  JUBILANT LIFE SCIENCES  STRIDES PHARMA SCIENCE  



Today's Market

Indian Indices Dip After Record Rally; Sensex Ends 298 Points Lower(Closing)

It was a volatile day for Indian share markets today. The BSE Sensex and NSE Nifty opened at record high and went on to touch 40,000 and 12,000.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


May 23, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - PANACEA BIOTECH COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS